Bio
StockEdge
Companies
News Brief
Editor’s Note
Pricing
Sign In
SUPN
SUPN
Overview
Pipeline
Financials
Ownership
Catalysts
Analyst
Pipeline Summary
0 total trials
0
Phase 1
0
Phase 2
0
Phase 3
0
Phase 4
BioScore
1
/10
High Risk
Science
(20%)
▸
1/10
Clinical
(25%)
▸
1/10
Data
(20%)
▸
1/10
Competitive
(15%)
▸
1/10
Regulatory
(20%)
▸
1/10
Data last updated: Jul 12, 2026, 07:35 PM
